Additional Post Hoc Analysis and Clinical Data Collection
- Conditions
- Neurological Observations
- Registration Number
- NCT02860416
- Lead Sponsor
- ElMindA Ltd
- Brief Summary
The purpose of this study is to collect additional Investigational cognitive tasks and additional clinical data for subjects tested with ElMindA's Brain Network Activation (BNA™).
- Detailed Description
To collect additional Investigational cognitive tasks and additional clinical data for subjects tested with ElMindA's Brain Network Activation (BNA™).
The BNA™ technology was developed and is utilized by ElMindA Ltd. The (BNA™) Analysis System is cleared for use by qualified medical professionals for the post hoc statistical analysis of the human electroencephalogram ("EEG"), utilizing evoked response potentials ("ERP').
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 55
- Completed a BNA test in the past
- Able to speak, read and understand English sufficiently to understand the nature of the study, and to allow completion of all study assessments.
- Willingness to participate
- Significant Sensory deficit
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method engineering development according to clinical assessments 2 years The study is designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical assessments and BNA scores. The results are primarily intended for scientific inquiry and engineering development purposes.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
ElMindA
🇺🇸Glenview, Illinois, United States
Premier Psychiatric Group
🇺🇸Lincoln, Nebraska, United States